ALTOMARI ALFRED 4
4 · AGILE THERAPEUTICS INC · Filed Mar 23, 2021
Insider Transaction Report
Form 4
ALTOMARI ALFRED
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2021-03-23$2.00/sh+12,500$25,030→ 468,710 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $1.9950 to $2.0050, inclusive. The reporting person undertakes to provide to Agile Therapeutics, Inc., any security holder of Agile Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.